Company News

The Hash Corporation (CSE: REZN) (OTC: REZNF) ("HashCo" or the "Company"), a business focusing on the production of hashish and other premium cannabis products using the adaption of old-world traditions, is pleased to announce that has received product listings from the Ontario Cannabis Store ("OCS") for its craft-style Gold Seal Hash and Cold Tumbled Resin. The two high quality nostalgic hash products are now available online at ocs.ca and through an expanding number of Ontario retail locations.

OCS is the largest provincial distributor of cannabis products in Canada and the only online retailer and wholesaler of legal recreational cannabis in Ontario. Wholly owned by the Province of Ontario, OCS works with Licensed Producers authorized by Health Canada. All of Ontario's Licensed Retailers purchase their product inventory through the OCS.

"These, our first product listings, mark the achievement of another significant milestone for us and should come as welcome news for Ontario consumers with an appetite for authentic, traditional hashish tastes, smells, and experiences," said Chris Savoie, the Chief Executive Officer and Director of HashCo.

About The Hash Corporation

The Hash Corporation ("HashCo") is a Canadian company positioning itself to focus on the production and sale of cannabis-based hashish and other cannabis products. HashCo intends to apply its separation and curing techniques to produce a suite of high-quality cannabis resin products, which are all-natural and free of additives and carcinogenic solvents. The Company intends to tailor its product offerings to pay tribute to historic traditions, fragrances and tastes, while upholding the highest health and safety standards.

As of the date of this press release, HashCo is actively seeking and developing partnerships and collaborations with licensed cultivators and other strategic partners within Canada, with the goal of crafting and introducing to the regulated market authentic products which reflect quality and innovation.

Forward-Looking Statements

This news release contains "forward-looking statements" within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking statements.

Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved". The forward-looking information and forward-looking statements contained herein include, but are not limited to, statements regarding the ability of the Company to develop partnerships with licensed cultivators and other strategic partners in Canada.

Forward-looking information in this news release are based on certain assumptions and expected future events, namely: the Company's ability to continue as a going concern; the continued commercial viability and growth in popularity of the Company's products; continued approval of the Company's activities by the relevant governmental and/or regulatory authorities; and the continued growth of the Company.

These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to: the potential inability of the Company to continue as a going concern; the risks associated with the cannabis industry in general; increased competition in the cannabis market; the potential future unviability of the Company's products; risks associated with potential governmental and/or regulatory action with respect to the cannabis products; risks associated with a potential collapse in the value of cannabis products; risks associated with the Company's ability to continue generating a profit; and the inability of the Company to develop partnerships with licensed cultivators and other strategic partners in Canada.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.

For further information:

Chris Savoie
Chief Executive Officer and Director
Tel: 1-833-420-7396
Email: chris@hashco.ca

Stephen Kilmer
Investor Relations
Tel: 1-647-872-4849
Email: stephen@kilmerlucas.com


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

hash company

The Hash Corporation

Overview

The global legal cannabis market is seeing unprecedented growth in recent years. In 2020, the market size stood valued at US$24.6 billion, with market researchers projecting market expansion at a compound annual growth rate of 14.3 percent from 2021 to 2028.

Changing regulations have led to increasing innovation in cannabis applications such as medical and pharmaceutical uses worldwide. As cannabis blends into more industries, investors should see substantial investment opportunities and possible exposure to wildly prospective markets.

The Hash Corporation (CSE:REZN) is a Canadian company focused on the production of cannabis-based hashish and other premium cannabis products. Using the adaption of old-world traditions, the company aims to safely deliver authentic hashish experiences crafted to modern standards and regulations.

Through strategic relationships in global cannabis jurisdictions worldwide, The Hash Corporation has created a unique blend of nostalgic hashish tastes, smells and cultures to contemporary legal markets. The company dedicates much of its operations to developing innovative and high-quality products with license holders to bring premium products to market.

The Hash Corporation is also actively monitoring the evolving legal frameworks abroad to stage a strategic entrance into emerging cannabis markets internationally. In prospective markets like Spain, Pakistan, Morocco and Afghanistan, hashish has broader appeal and consumption than the plant counterpart, making for potential expansion.

The company has secured licensed processing space and commenced operations in the heart of Toronto to produce white-label and The Hash Corporation branded products in April 2020. Strategic positioning in such a populous and advanced city allows The Hash Corporation to leverage a broad consumer base, supportive legal regulations and excellent infrastructure.

The company’s diverse business network enables significant growth potential by utilizing the collective strengths across exciting emerging industries. Some strategic relationships include First Republic Capital, Medz Cannabis Inc., Maratek and Black Rose Organics.

“We’re not like many other license holders in the cannabis space. We’re selecting partners to work with to add value to their product and extract value for us through our processes. We’ve developed a low-cost production model whereby we don’t have the overhead of maintaining our own facility, giving us kind of a clear path to breakeven and in the next quarter, projected profitability before the end of the year,” commented The Hash Corporation CEO Chris Savoie.

The company anticipates public listing on the Canadian Stock Exchange, finalizing its second 12-month production contract and the commencement of wholesale distribution capabilities of hash products in 2021. The Hash Corporation has commenced commercial-scale operations and the occupation of full-scale custom-designed processing space at Medz Cannabis Inc.

The company’s well-engineered business execution strategy enables increased profit potential through long-term product development contracts, focus on strategic collaboration opportunities and honing the emerging global market to maximize shareholder value.

In March 2021, the company announced it completed a non-brokered private placement for gross proceeds of CAD$1,505,000 through the issuance of 10,050,000 common shares at CAD$0.10 per share. The Hash Corporation has a solid capital structure, which currently stands at 239,270,000 common shares.

The Hash Corporation’s management team consists of leaders in the cannabis industry with years of corporate management, product development, finance and cannabis industry experience. Their vest interest in the success of The Hash Corporation primes the company for exceptional growth potential and economic accomplishments.

The Hash Corporation’s Company Highlights

  • The Hash Corporation is a Canadian cannabis company focused on producing and selling cannabis-based hashish and other premium cannabis products. It is dedicated to creating a unique nostalgic experience that consumers can resonate with.
  • The company has existing white-label partnerships and has generated revenue in 2021, with profitability projected by the end of 2021.
  • The Hash Corporation is currently in discussion with US partners to enter the California market with its branded products. Future expansion plans point to potential international distribution in emerging markets around the world. Shifts in legal frameworks present tremendous expansion potential.
  • The company’s leadership comprises industry experts with a proven track record of management successes aligned with shareholders and stakeholder interests. This passionate management team has deep roots in the cannabis space and leverage world-class expertise on the market.
  • The Hash Corporation anticipates public listing on the Canadian Stock Exchange in early 2021. Solid capital structuring and a recently completed non-brokered private placement present good cash positioning for development and financial growth.


The Hash Corporation’s Service Pipeline: The Hash Corporation

The Hash Corporation works with licensed cultivators to craft authentic, traditional Hashish products and experiences focusing on quality and innovation in regulated markets. The company provides an array of hashish and cannabis-focused services, including separation, finishing, breeding and innovative product development. Its expert blend of traditional and modern processing techniques creates premium hashish and resin products that create unique and nostalgic experiences for its customers.

The Hash Corporation’s Management Team

Chris Savoie — CEO

Chris Savoie is a world traveler and entrepreneur who began his work with medical cannabis in 2004 under the former MMAR. While working full time in sales and project management, he built a wealth of knowledge as a grower, extractor and cannabis product developer, working to relieve his father’s M.S symptoms. Savoie’s skills in a wide range of extraction methodologies and experience selecting cultivars with ideal characteristics for those processes have been integral to developing several award-winning legacy cannabis brands. A renowned hashmaker, Savoie brings over 17 years of expertise, business acumen and powerful industry networking to the new era of regulated cannabis extract products.

Keep reading...Show less

Trulieve Opening Morgantown, WV Medical Dispensary

New dispensary expands patient access to medical cannabis; grand opening specials available

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States today announced the grand opening of a new medical dispensary in Morgantown - Granville, WV . Located at 525 Granville Square, the doors open at 10 a.m. on Friday, July 1, 2022 .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Trulieve Opening Coral Springs, FL Medical Dispensary

New dispensary expands patient access to medical cannabis; grand opening specials available

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States today announced the opening of a new medical dispensary in Coral Springs, Florida . Located at 10400 W. Atlantic Blvd., the doors will open at 9am on Friday, July 1, 2022 . The dispensary will be open seven days a week, hours are Monday through Saturday from 9am 9pm and on Sunday from 10am 8pm .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Canopy Growth Announces Additional Exchanges with Holders of Notes

 Canopy Growth Corporation (" Canopy Growth " or the " Company ") (TSX: WEED) (NASDAQ: CGC) announced today that, further to its press release dated June 29, 2022 it has entered into an additional privately negotiated exchange agreement (the " Exchange Agreement ") with a holder (the " Noteholder ") of the Company's outstanding 4.25% unsecured senior notes due 2023 (the " Notes "), to acquire approximately C$7.25 million (approximately USD$5.6 million ) aggregate principal amount of the Notes from the Noteholders in exchange for common shares of the Company (the " Canopy Shares ") and approximately C$140,000 (approximately USD$110,000 ) in cash for accrued and unpaid interest (the " Cash Payment ").

Canopy Growth Announces Additional Exchanges with Holders of Notes (CNW Group/Canopy Growth Corporation)

Transaction Details

In accordance with the terms of the Exchange Agreement, Canopy Growth has agreed to acquire the Notes from the Noteholder for an aggregate purchase price (excluding accrued and unpaid interest which will be paid in cash as part of the Cash Payment) of C$7.17 million (approximately USD$5.5 million ) (the " Purchase Price "), which will be payable in such number of Canopy Shares (the " Share Consideration ") as is equal to the Purchase Price divided by the volume-weighted average trading price (the " VWAP ") of the Canopy Shares on the Nasdaq Global Select Market (the " Nasdaq ") for the 10 consecutive trading days beginning on, and including, June 30, 2022 (the " Averaging Price " and such period of time being the " Averaging Period "), subject to a floor price of US$2.50 (the "Floor Price") and a maximum price equal to US$3.50 , which is the closing price of the Canopy Shares on the Nasdaq on June 29, 2022 (the " Market Price ").

The Share Consideration will be satisfied by the issuance of Canopy Shares in up to two tranches as follows: (a) on the initial closing, 1,589,260 Canopy Shares (the " Initial Closing Shares ") will be issued to the Noteholder; and (b) in the event that the Averaging Price calculated over the Averaging Period is less than the Market Price, on or about July 18, 2022 (the " Final Closing "), up to such number of Canopy Shares as is equal to the excess of the Purchase Price divided by the Averaging Price over the Initial Closing Shares.

In the event that the daily VWAP of the Canopy Shares on the Nasdaq during the Averaging Period (a) exceeds the Market Price, then the daily VWAP for such trading day will instead be deemed to be the Market Price; or (b) is less than the Floor Price, then the daily VWAP for such trading day will instead be deemed to be the Floor Price, such that in no circumstances will more than 2,224,965 Canopy Shares be issuable pursuant to the Noteholder.

Together with the exchange agreements (the " Other Exchange Agreements ") entered into prior to the announcement on June 29, 2022 (collectively, the " Transaction "), a minimum of 35,662,420 Canopy Shares have been or will be issued. Pursuant to the terms of the Exchange Agreement and the Other Exchange Agreements, in no circumstances will more than 80,629,270 Canopy Shares be issuable pursuant to the Transaction.

The Transactions are being conducted as private placements, and any Canopy Shares to be issued in the Transaction will be issued pursuant to the exemption from the registration requirements of the Securities Act of 1933, as amended (the " Securities Act "), afforded by Section 4(a)(2) of the Securities Act in transactions not involving any public offering. This press release is neither an offer to sell nor a solicitation of an offer to buy any securities described above, nor will there be any offer, solicitation or sale of any securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About Canopy Growth

Canopy Growth (TSX:WEED, NASDAQ:CGC) is a world-leading diversified cannabis and cannabinoid-based consumer product company, driven by a passion to improve lives, end prohibition, and strengthen communities by unleashing the full potential of cannabis. Leveraging consumer insights and innovation, Canopy Growth offers product varieties in high-quality dried flower, oil, softgel capsule, infused beverage, edible, and topical formats, as well as vaporizer devices by Canopy Growth and industry-leader Storz & Bickel. Canopy Growth's global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany . Through Canopy Growth's award-winning Tweed and Tokyo Smoke banners, Canopy Growth reaches its adult-use consumers and has built a loyal following by focusing on top quality products and meaningful customer relationships. Canopy Growth has entered into the health and wellness consumer space in key markets including Canada , the United States , and Europe through BioSteel sports nutrition, and This Works skin and sleep solutions; and has introduced additional hemp derived CBD products to the United States through its First & Free and Martha Stewart CBD brands. Canopy Growth has an established partnership with Fortune 500 alcohol leader Constellation Brands.

Notice Regarding Forward-Looking Information

This news release contains "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and "forward-looking information" within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release. Examples of such statements and uncertainties include statements with respect to the benefits of the debt repurchase, the anticipated date of issuance of the Initial Closing Shares, the anticipated date of the issuance of any additional Canopy Shares following the Averaging Period and expectations for other economic, business, and/or competitive factors .

Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including inherent uncertainty associated with projections; the diversion of management time on Transaction-related issues; expectations regarding future investment, growth and expansion of operations; regulatory and licensing risks; changes in general economic, business and political conditions, including changes in the financial and stock markets and the impacts of increased rates of inflation; legal and regulatory risks inherent in the cannabis industry, including the global regulatory landscape and enforcement related to cannabis, political risks and risks relating to regulatory change; risks relating to anti-money laundering laws; compliance with extensive government regulation and the interpretation of various laws regulations and policies; public opinion and perception of the cannabis industry; and such other risks contained in the public filings of the Company filed with Canadian securities regulators and available under the Company's profile on SEDAR at www.sedar.com and with the United States Securities and Exchange Commission through EDGAR at www.sec.gov/edgar , including the Company's annual report on Form 10-K for the year ended March 31, 2022 .

In respect of the forward-looking statements and information, the Company has provided such statements and information in reliance on certain assumptions that they believe are reasonable at this time. Although the Company believes that the assumptions and factors used in preparing the forward-looking information or forward-looking statements in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. Should one or more of the foregoing risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The forward-looking information and forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information or forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities laws.

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/canopy-growth-announces-additional-exchanges-with-holders-of-notes-301579205.html

SOURCE Canopy Growth Corporation

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2022/30/c3730.html

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Centurion Announces Effective Date of Share Consolidation

Centurion Minerals Ltd. (TSXV: CTN) (the "Company") announces that the consolidation of its common shares will become effective July 6, 2022, and all common shares will be consolidated on a 2:1 basis, such that for every 2 common shares presently held, shareholders will receive 1 post-consolidated common share.

Centurion currently has 33,639,473 common shares outstanding which will, on a post-consolidation basis, result in approximately 16,819,736 common shares outstanding. There are no stock options or warrants outstanding and the Company's name and trading symbol will remain the same.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

Tyson 2.0 Completes $9 Million Series A to Expand Celebrity Brand Portfolio

Round Led by JW Asset Management to Advance House of Brands Strategy

Tyson 2.0 is Licensed in over 20 States and has Sold Over 4,000 lbs of Cannabis Flower

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

Canopy Growth Celebrates Summer with New 'Just Hits Different' Beverage Campaign

Leading global cannabis company continues to expand beverage portfolio with exciting new products

Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC), a world-leading diversified cannabis, hemp, and cannabis device company, today announced the continued expansion of its cannabis beverage portfolio and a brand campaign that drives awareness of its wide range of cannabis beverages just in time for the summer season. Boasting the category's fastest growing brands, 1 Canopy Growth continues to show its leadership in beverages and ongoing commitment to meeting customer demand.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×